Acurx Pharmaceuticals, Inc.
ACXP
$1.43
$0.00-0.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.10% | -6.51% | 20.80% | 11.29% | -4.52% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.84% | -15.03% | 10.56% | -17.18% | -7.51% |
| Change in Net Operating Assets | 673.58% | -358.76% | 107.76% | -237.93% | 147.77% |
| Cash from Operations | -21.49% | -18.81% | 37.02% | -12.59% | 18.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -1.67% | 5.24% | 72.73% | -44.20% | 3.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | 80.14% | -14,400.00% | -- | -- |
| Cash from Financing | 0.17% | 9.60% | 64.42% | -44.23% | 3.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.49% | 3.00% | 1,148.51% | -111.08% | 51.54% |